Back to Search
Start Over
Biosimilars and drug development in allergic and immunologic diseases
- Source :
- Journal of allergy and clinical immunology 139 (2017): 1461–1464. doi:10.1016/j.jaci.2017.03.008, info:cnr-pdr/source/autori:Bonini S.; Bonini M./titolo:Biosimilars and drug development in allergic and immunologic diseases/doi:10.1016%2Fj.jaci.2017.03.008/rivista:Journal of allergy and clinical immunology/anno:2017/pagina_da:1461/pagina_a:1464/intervallo_pagine:1461–1464/volume:139
- Publication Year :
- 2017
- Publisher :
- Mosby, St. Louis, Mo. , Stati Uniti d'America, 2017.
- Subjects :
- precision medicine
Immunology
Allergic
biologics
Animals
Anti-Allergic Agents
Antirheumatic Agents
Biological Products
Biosimilar Pharmaceuticals
Drugs, Generic
Europe
Humans
Hypersensitivity
Immune System Diseases
United States
Drug Development
Immunology and Allergy
Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO
030204 cardiovascular system & hematology
03 medical and health sciences
Immunologic diseases
0302 clinical medicine
Medicine
030212 general & internal medicine
business.industry
Biosimilar
personalized medicine
asthma
Drug development
biosimilar
business
biologic
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Journal of allergy and clinical immunology 139 (2017): 1461–1464. doi:10.1016/j.jaci.2017.03.008, info:cnr-pdr/source/autori:Bonini S.; Bonini M./titolo:Biosimilars and drug development in allergic and immunologic diseases/doi:10.1016%2Fj.jaci.2017.03.008/rivista:Journal of allergy and clinical immunology/anno:2017/pagina_da:1461/pagina_a:1464/intervallo_pagine:1461–1464/volume:139
- Accession number :
- edsair.doi.dedup.....0fd84b7b8e4bdb48a570b4db8f50895b
- Full Text :
- https://doi.org/10.1016/j.jaci.2017.03.008